Press release
03.03.2021 To the attention of interested persons EMA press release: Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers […]
Press release
23.02.2021 To the attention of interested persons EMA press release: EMA starts evaluating use of Veklury in COVID-19 patients not […]
Press release
23.02.2021 To the attention of interested persons EMA press release: Precautionary marketing suspension of thalassaemia medicine Zynteglo download document …
Important notification
22.02.2021 To the attention of Marketing Authorisation Holders UK withdrawal from the European Unit On the 31st December 2020, the […]
Press release
18.02.2021 To the attention of interested persons EMA press release: EMA receives application for conditional marketing authorisation of COVID-19 Vaccine […]
Press release
16.02.2021 To the attention of interested persons EMA press release: Review of amfepramone medicines started download document …
Important notification
15.02.2021 To the attention of marketing authorisation holders Request for assessment of the risk of the presence of nitrosamine impurities […]
Press release
12.02.2021 To the attention of interested persons EMA press release: EMA starts rolling review of CureVac’s COVID-19 vaccine (CVnCoV) download […]
Press release
11.02.2021 To the attention of interested persons EMA press release: Clarification on Sputnik V vaccine in the EU approval process […]
Press release
08.02.2021 To the attention of interested persons EMA press release: EMA reviewing data on monoclonal antibody use for COVID-19 download […]